Filing Details
- Accession Number:
- 0001179110-18-012212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-17 09:51:16
- Reporting Period:
- 2018-10-16
- Accepted Time:
- 2018-10-17 09:51:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 855654 | Immunogen Inc | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691868 | Anna Berkenblit | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02152 | Vp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-16 | 5,851 | $8.00 | 132,769 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Weighted average price of shares sold.
- The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person.
Billionaire Hedge Funds
